Monday, April 01, 2024 12:27:25 PM
Operating revenue $949,438 for 2023, compared to $1,076,286 for 2022, a decrease of $126,848, or 12%.
Net operating income $120,542 for 2023 compared to net loss of $342,204 for 2022. This result is due to reducing expenses significantly in 2023.
Other income decreased by $661,886 during 2023 (robotic arm license one time benefit). Interest expenses increased to $185,452 in 2023 from 152,803 in 2022.
Net loss $58,910 during 2023 as compared to a net income of $166,879 realized during 2022.
So basically revenue declined a little and they significantly cut expenses and labor - using contract labor only so they have no actual full time employees.
Interesting how Shaun is basically just moving money around between his companies:
The Company recognized other revenue of $661,886 for permanent licensing of the Robotic Arm patent to ZenaTech, Inc., a related party. ZenaTech, Inc.’s controlling shares are owned equally by Epazz, Inc. and Shaun Passley, PhD. Shaun Passley, PhD is the President of both Ameritek and Epazz, Inc., their Chief Executive Officer and majority shareholder.
Recent ATVK News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 12:53:27 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM